11. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. (26th February 2015) Authors: Köhler, Michael; Haag, Susanne; Biester, Katharina; Brockhaus, Anne Catharina; McGauran, Natalie; Grouven, Ulrich; Kölsch, Heike; Seay, Ulrike; Hörn, Helmut; Moritz, Gregor; Staeck, Kerstin; Wieseler, Beate Journal: BMJ Issue: Volume 350(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs. Issue 1 (2nd July 2015) Authors: Skipka, Guido; Wieseler, Beate; Kaiser, Thomas; Thomas, Stefanie; Bender, Ralf; Windeler, Jürgen; Lange, Stefan Journal: Biometrical journal Issue: Volume 58:Issue 1(2016:Jan.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. New drugs: where did we go wrong and what can we do better?. (10th July 2019) Authors: Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas Journal: BMJ Issue: Volume 366(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Pathways to independence: towards producing and using trustworthy evidence. (3rd December 2019) Authors: Moynihan, Ray; Bero, Lisa; Hill, Sue; Johansson, Minna; Lexchin, Joel; Macdonald, Helen; Mintzes, Barbara; Pearson, Cynthia; Rodwin, Marc A; Stavdal, Anna; Stegenga, Jacob; Thombs, Brett D; Thornton, Hazel; Vandvik, Per Olav; Wieseler, Beate; Godlee, Fiona Journal: BMJ Issue: Volume 367(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. (12th October 2010) Authors: Eyding, Dirk; Lelgemann, Monika; Grouven, Ulrich; Härter, Martin; Kromp, Mandy; Kaiser, Thomas; Kerekes, Michaela F; Gerken, Martin; Wieseler, Beate Journal: BMJ Issue: Volume 341(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?. (2nd March 2023) Authors: Wieseler, Beate; Neyt, Mattias; Kaiser, Thomas; Hulstaert, Frank; Windeler, Jürgen Journal: BMJ Issue: Volume 380(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Still waiting for functional EU Clinical Trials Register. (20th June 2011) Authors: Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas Journal: BMJ Issue: Volume 342(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. We need access to data on all clinical trials, not just some. (26th November 2012) Authors: Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas Journal: BMJ Issue: Volume 345(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗